Laporte Kathleen
- SEC CIK
- 0001196201
No open-market purchases or sales filed in the past year.
Current role at each company
- QTTB Q32 Bio Inc.Directoras of Jul 21, 2026
- BOLT Bolt Biotherapeutics, Inc.Directoras of Jun 11, 2026
- PRPO Precipio, Inc.Directoras of Jan 20, 2026
- CERO Cero Therapeutics Holdings, Inc.Directoras of Jan 9, 2026
- ETNB 89bio, Inc.Directoras of Oct 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Laporte Kathleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRPO Precipio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2025 (view filing) | Sep 8 | 2 days | Laporte KathleenDirector | SSale | −6.15K | $20.06 | −$123.4K | −50.0%6.15K after |
ETNB 89bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2023 (view filing) | Jul 17 | 1 day | Laporte KathleenDirector | SSale | −12.5K | $18.80 | −$235.0K | −100.0%0 after |